SwingTrade Member Forum

[Rawnoc]

VVUS -- "The actual wording of the FDA’s rejection, called a Complete Response Letter (CRL), is considered confidential, so investors should be cautious in analyzing it as filtered through Vivus’ press release."

http://blogs.forbes.com/matthewherper/2010/10/28/vivus-diet-drug-denied/?partner=yahootix